November 11, 2013 | Israeli company Lumenis, a medical device company, is planning to raise $100 million on Nasdaq at a company value of up to $500 million (after money). “Globes” reports that the already publicly-traded company has set a target date of February 14 to return Nasdaq.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Clean Energy Firm Completes Solar Project In North, South Israel
October 15, 2024
Cannabis Therapy Firm: CBD Jab Reduces Pain In Arthritic Dogs
October 15, 2024
US Government Funding Development Of Israeli Ebola Treatment
October 14, 2024
Security Firm Wins Prison Service Contract For Electronic Monitoring
October 14, 2024
Facebook comments